|  | | |  | |
|---|
| 1 |
 | ALL |
| |
| 2 |
| Angiomyolipoma |
| |
| 3 |
| Bellini Duct Carcinoma |
| |
| 4 |
| Chromophobe RCC |
| |
| 5 |
| Clear Cell RCC |
| |
| 6 |
| Collecting Duct Carcinoma |
| |
| 7 |
| Cystic RCC |
| |
| 8 |
| No Subtype Identified |
| |
| 9 |
 | No Subtype Specified |
| |
| 9.1 | | Phase 3 trial of everolimus for metastatic renal cell carcinoma : final results and analysis of prognostic factors | docguide.com | Sep 15, 2010 | |
| 9.2 | | Sunitinib and sorafenib in metastatic renal cell carcinoma patients with renal insufficiency | DocGuide | Jan 20, 2010 | |
| 9.3 | | Association of Skeletal Muscle Wasting With Treatment With Sorafenib in Patients With Advanced Renal Cell Carcinoma: Results From a Placebo-Controlled Study | DocGuide | Jan 19, 2010 | |
| 9.4 | | FDA Drug Approval Summary: Bevacizumab plus Interferon for Advanced Renal Cell Carcinoma | DocGuide | Jan 8, 2010 | |
| 9.5 | | Bevacizumab safety in patients with central nervous system metastases | DocGuide | Jan 1, 2010 | |
| 9.6 | | Reduction in skin microvascular density and changes in vessel morphology in patients treated with sunitinib. | DocGuide | Dec 31, 2009 | |
| 9.7 | | Vorinostat Enhances the Activity of Temsirolimus in Renal Cell Carcinoma Through Suppression of Survivin Levels | http://clincancerres.aacrjournals.org | Dec 22, 2009 | |
| 9.8 | | New kidney cancer drug gets TGA tick | Life Scientist | Nov 19, 2009 | |
| 9.9 | | Phase I trial of an allogeneic gene-modified tumor cell vaccine (RCC-26/CD80/IL-2) in patients with metastatic renal cell carcinoma - Abstract | UROTODAY | Oct 29, 2009 | |
| 9.10 | | Everolimus: in advanced renal cell carcinoma. | DocGuide | Oct 22, 2009 | |
| 9.11 | | FDA Approves GlaxoSmithKline's VOTRIENT For Advanced Renal Cell Cancer | Medical News Today | Oct 20, 2009 | |
| 9.12 | | Kidney Cancer Drug May Cause Liver Damage: FDA | HER News | Oct 2, 2009 | |
| 9.13 | | Tumor-Reducing Surgery Boosts Drug Effect in Metastatic Kidney Cancer | Medpage Today | Sep 29, 2009 | |
| 9.14 | | FDA Approves Avastin for Most Common Kidney Cancer | HER News | Aug 4, 2009 | |
| 9.15 | | Phase II experience with MDX-1106 (Ono-4538), an anti-PD-1 monoclonal antibody, in patients with selected refractory or relapsed malignancies | Journal of Clinical Oncology | May 20, 2009 | |
| 9.16 | | Randomized Phase II Trial of First-Line Treatment With Sorafenib Versus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma | Journal of Clinical Oncology | Mar 1, 2009 | |
| 9.17 | | A Friendly Skeptic Looks at Goji Juice | CancerDecisions.com Newsletter | Jan 1, 2005 | |
| 9.18 | | Solitary pancreatic metastasis from renal cell carcinoma 14 years after nephrectomy: a case report | PubMed | Sep 1, 2004 | |
| 10 |
| Non-Clear Cell RCC |
| |
| 11 |
| Oncocytoma |
| |
| 12 |
| Papillary RCC |
| |
| 13 |
| Papillary (Chromophil) |
| |
| 14 |
| Papillary (unspecified) RCC |
| |
| 15 |
| Pediatric RCC |
| |
| 16 |
| Renal medullary carcinoma |
| |
| 17 |
| Sarcomatoid RCC |
| |
| 18 |
| Squamous RCC |
| |
| 19 |
| Unknown |
| |
| 20 |
| (Not Categorized) |
| |